The effect on lymphocyte subsets of decreasing/stopping tyrosine kinase inhibitor therapy in chronic myeloid leukaemia: data from the DESTINY trial. (8th November 2018) - Austin, Gemma M.; Knight, Katy; Bell, Joanne; Carter, Anthony; Heartin, Earnest; Watson, David; Foroni, Letizia; Christmas, Stephen E.; Polydoros, Fotios; Clark, Richard E.